Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 701 citing articles:

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 543-558
Open Access | Times Cited: 1303
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R. Mehra, Sapan S. Desai, Frank Ruschitzka, et al.
The Lancet (2020)
Open Access | Times Cited: 1209
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Anant Parasher
Postgraduate Medical Journal (2020) Vol. 97, Iss. 1147, pp. 312-320
Open Access | Times Cited: 705
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 3, pp. 359-386
Open Access | Times Cited: 587
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, et al.
Med (2020) Vol. 1, Iss. 1, pp. 114-127.e3
Open Access | Times Cited: 585
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
Wesley H. Self, Matthew W. Semler, Lindsay Leither, et al.
JAMA (2020) Vol. 324, Iss. 21, pp. 2165-2165
Open Access | Times Cited: 401
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H.M. Furtado, Otávio Berwanger, Henrique Fonseca, et al.
The Lancet (2020) Vol. 396, Iss. 10256, pp. 959-967
Open Access | Times Cited: 360
Covid-19 and the cardiovascular system: a comprehensive review
Rafael Bellotti Azevedo, Bruna Gopp Botelho, João Victor Gonçalves de Hollanda, et al.
Journal of Human Hypertension (2020) Vol. 35, Iss. 1, pp. 4-11
Open Access | Times Cited: 335
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU
Damien Contou, Aurore Claudinon, Olivier Pajot, et al.
Annals of Intensive Care (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 294
Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
Natàlia Casamitjana, Marc Corbacho-Monné, María Ubals, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e4073-e4081
Open Access | Times Cited: 278
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
Ehud Chorin, Lalit Wadhwani, Silvia Magnani, et al.
Heart Rhythm (2020) Vol. 17, Iss. 9, pp. 1425-1433
Open Access | Times Cited: 268
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Natàlia Casamitjana, Marc Corbacho-Monné, María Ubals, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 5, pp. 417-427
Open Access | Times Cited: 234
Azithromycin in the treatment of COVID-19: a review
Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 147-163
Open Access | Times Cited: 233
Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey
Jean Franco Quispe-Cañari, Evelyn Fidel-Rosales, Diego Manrique, et al.
Saudi Pharmaceutical Journal (2020) Vol. 29, Iss. 1, pp. 1-11
Open Access | Times Cited: 231
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
James E. Tisdale, Mina K. Chung, Kristen Bova Campbell, et al.
Circulation (2020) Vol. 142, Iss. 15
Open Access | Times Cited: 223
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 2
Open Access | Times Cited: 223
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 4, pp. 287-296
Closed Access | Times Cited: 220
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim, Min Ho An, Won Jun Kim, et al.
PLoS Medicine (2020) Vol. 17, Iss. 12, pp. e1003501-e1003501
Open Access | Times Cited: 203
The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review
Andrew Y. Chang, Mark R. Cullen, Robert A. Harrington, et al.
Journal of Internal Medicine (2020) Vol. 289, Iss. 4, pp. 450-462
Open Access | Times Cited: 194
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
Lior Jankelson, Giorgio Karam, Matthijs L. Becker, et al.
Heart Rhythm (2020) Vol. 17, Iss. 9, pp. 1472-1479
Open Access | Times Cited: 185
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Kathleen Chiotos, Molly Hayes, David W. Kimberlin, et al.
Journal of the Pediatric Infectious Diseases Society (2020) Vol. 9, Iss. 6, pp. 701-715
Open Access | Times Cited: 183
Arrhythmias and COVID-19
Parinita Dherange, Joshua Lang, Pierre Qian, et al.
JACC. Clinical electrophysiology (2020) Vol. 6, Iss. 9, pp. 1193-1204
Open Access | Times Cited: 149
Methodological quality of COVID-19 clinical research
Richard G. Jung, Pietro Di Santo, Cole Clifford, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 147
Page 1 - Next Page

Scroll to top